Home > Research > Publications & Outputs > Should deceased donation be morally preferred i...

Electronic data

  • Williams-2016-Bioethics

    Rights statement: © 2016 The Authors Bioethics Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Final published version, 172 KB, PDF document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

Links

Text available via DOI:

View graph of relations

Should deceased donation be morally preferred in uterine transplantation trials?

Research output: Contribution to journalJournal article

Published
<mark>Journal publication date</mark>07/2016
<mark>Journal</mark>Bioethics
Issue number6
Volume30
Number of pages10
Pages (from-to)415-424
Publication StatusPublished
Early online date1/02/16
<mark>Original language</mark>English

Abstract

In recent years much research has been undertaken regarding the feasibility of the human uterine transplant (UTx) as a treatment for absolute uterine factor infertility (AUFI). Should it reach clinical application this procedure would allow such individuals what is often a much-desired opportunity to become not only social mothers (via adoption or traditional surrogacy arrangements), or genetic and social mothers (through gestational surrogacy) but mothers in a social, genetic and gestational sense. Like many experimental transplantation procedures such as face, hand, corneal and larynx transplants, UTx as a therapeutic option falls firmly into the camp of the quality of life (QOL) transplant, undertaken with the aim, not to save a life, but to enrich one. However, unlike most of these novel procedures – where one would be unlikely to find a willing living donor or an ethics committee that would sanction such a donation – the organs to be transplanted in UTx are potentially available from both living and deceased donors.

In this paper, in light of the recent nine-case research trial in Sweden which used uteri obtained from living donors, and the assertions on the part of other research teams currently preparing trials that they will only be using deceased donors, I explore the question of whether, in the case of UTx, there exist
compelling moral reasons to prefer the use of deceased donors despite the benefits that may be associated with the use of organs obtained from the living.

Bibliographic note

© 2016 The Authors Bioethics Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.